The Goldman Sachs Group Lowers Bath & Body Works (NYSE:BBWI) Price Target to $23.00

Bath & Body Works (NYSE:BBWIGet Free Report) had its target price reduced by research analysts at The Goldman Sachs Group from $26.00 to $23.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective points to a potential upside of 17.56% from the stock’s current price.

Several other equities research analysts also recently weighed in on the stock. UBS Group lowered their target price on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, May 20th. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a report on Monday, April 20th. Barclays set a $23.00 price objective on shares of Bath & Body Works in a report on Thursday. Citigroup cut shares of Bath & Body Works from a “buy” rating to a “neutral” rating and lifted their price objective for the company from $21.00 to $25.00 in a report on Tuesday, February 17th. Finally, Telsey Advisory Group lifted their target price on shares of Bath & Body Works from $23.00 to $25.00 and gave the company a “market perform” rating in a research report on Thursday, March 5th. Three investment analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. According to data from MarketBeat.com, Bath & Body Works has an average rating of “Hold” and a consensus price target of $21.79.

View Our Latest Stock Analysis on BBWI

Bath & Body Works Stock Performance

NYSE BBWI opened at $19.56 on Thursday. The firm’s 50 day moving average price is $18.65 and its 200-day moving average price is $20.24. Bath & Body Works has a 52-week low of $14.27 and a 52-week high of $33.96. The company has a market cap of $3.94 billion, a PE ratio of 6.21, a P/E/G ratio of 1.76 and a beta of 1.43.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The firm had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same period last year, the firm earned $0.49 earnings per share. The company’s quarterly revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, analysts forecast that Bath & Body Works will post 2.61 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Bath & Body Works

Several institutional investors and hedge funds have recently bought and sold shares of BBWI. AQR Capital Management LLC boosted its holdings in Bath & Body Works by 132.5% in the 4th quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock valued at $229,834,000 after purchasing an additional 6,523,960 shares during the last quarter. American Century Companies Inc. boosted its holdings in Bath & Body Works by 2,204.1% in the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after purchasing an additional 4,949,796 shares during the last quarter. Jupiter Asset Management Ltd. boosted its holdings in Bath & Body Works by 553.2% in the 3rd quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock valued at $95,685,000 after purchasing an additional 3,145,797 shares during the last quarter. Norges Bank acquired a new position in Bath & Body Works in the 4th quarter valued at about $55,504,000. Finally, Balyasny Asset Management L.P. acquired a new position in Bath & Body Works in the 4th quarter valued at about $54,785,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works News Summary

Here are the key news stories impacting Bath & Body Works this week:

About Bath & Body Works

(Get Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

Featured Stories

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.